FDA approves first-in-class SYK inhibitor

被引：0

|

作者：

Asher Mullard

机构：

来源：

Nature Reviews Drug Discovery | 2018年 / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：385 / 385

相关论文

共 50 条

[41] Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Fala, Loretta
AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (06):
[42] Ezetimibe: A first-in-class novel cholesterol absorption inhibitor
Lipka, LJ
CARDIOVASCULAR DRUG REVIEWS, 2003, 21 (04): : 293 - 312
[43] FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (03) : 173 - 173
[44] FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 173 - 173
[45] FDA approves first deuterated drug
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (05) : 305 - 305
[46] FDA approves first RSV vaccine
不详
SCIENCE, 2023, 380 (6645) : 564 - 564
[47] FDA approves first chikungunya vaccine
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (01) : 8 - 8
[48] FDA approves first MASH drug
不详
NATURE BIOTECHNOLOGY, 2024, 42 (04) : 541 - 541
[49] FDA approves first digital pill
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (12) : 818 - 818
[50] FDA Approves First Celecoxib Generics
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (24): : 2470 - 2470

← 1 2 3 4 5 →